Business Wire

GRO Network™ Brings Environmental Transparency to Grain Market

1.9.2020 15:30:00 EEST | Business Wire | Press release

Share

Farmer’s Business Network, Inc. (FBNSM), the leading direct-to-farm ag tech platform and farmer network, today launched GRO Network, which provides new technology and services that facilitate the scoring, sourcing, and pricing of Low-Carbon Grain from farm to fork, making environmental transparency in the grain industry a reality now.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200901005290/en/

GRO Network enables comprehensive environmental transparency, and supports a market for premium, environmentally-scored grain. GRO Network also provides buying intelligence software that directly connects farmers with consumer packaged goods companies, animal feed providers, biofuel makers and the world’s other major grain buyers.

POET, the world’s largest producer of biofuels has joined GRO Network as a key customer in the market for verifiable Low-Carbon Grain.

“Family farms have already invested the time, innovation and sweat-equity to develop the regenerative practices required to grow Low-Carbon Grain,” said Amol Deshpande, CEO and Co-Founder of FBN. “With GRO Network, the efforts of farmers as well as food and feed companies, biofuel makers, and ordinary consumers to reduce carbon emissions just got a huge boost.”

Transparency in the agriculture supply chain starts with data direct from the field.

Farmers share information on their cultivation practices - including fertilizer applications, tillage, and cover cropping - with GRO Network, which is processed with artificial intelligence that leverage FBN’s 240 million acre-events of real world farm data, validates and distills the practices into a single farm-level score. This single score - which is the only information shared between GRO Network and prospective buyers - informs the buyer to then source premium grain as well as build programs to meet unique sustainability goals, while protecting farmers’ data privacy.

Importantly, verifiable Low-Carbon Grain will allow agricultural processors and food companies to meet their own significant emission goals. Policymakers will be able to evaluate a precise, farm-level carbon-intensity score to more accurately measure the GHG reduction of biofuels for low carbon fuel policies. GRO Network will help these companies embed the required carbon traceability into their supply chains, all within the current government policy framework.

“At POET we know that agriculture is the key to combating climate change, and we want to support farmers who share our mission to be good stewards of the earth by using environmentally friendly practices,” said POET Founder and CEO Jeff Broin. “We are excited about the potential of the GRO Network to promote sustainable agriculture and utilize the resulting Low-Carbon Corn to produce even greener bioethanol and bioproducts.”

GRO Network is focusing initially on carbon abatement, which, based on GRO Network pilots, can reduce grain emissions by up to 50%, while increasing farm revenues at the same time. It relies on proven, existing science and robust FBN analytics to measure the benefits of conservation activities on the farm, providing immediate, low-risk solutions to reduce the environmental impact of the agriculture supply chain.

“Regenerative agriculture techniques have not only saved us money, they’ve made us money,” said Todd Hanten, who farms 3,000 acres of corn, soybeans and spring wheat in South Dakota. “We’ve always tried these practices side by side and can compare conventional tillage to no-till and strip till and we’ve realized the benefits through our data analytics. We’re happy to find out that the practices we’ve adopted are saving us money and making us a better return.”

FBN began development of GRO Network close to two years ago in order to allow fuel, food and feed companies to work alongside farmers to accelerate the adoption of regenerative agricultural practices that deliver the biggest impact. GRO Network incentivizes sustainable conservation and soil health practices by producers, ensuring a consistent supply of high quality, Low-Carbon Grain for buyers.

“Ultimately, GRO Network aligns farmers, processors, brands, consumers and policy-makers in the fight against climate change,” Deshpande said. “We are excited to see family farm incomes improve as a direct result.”

Learn more at www.fbngro.com

About FBN:

Farmer’s Business Network, Inc. is an independent ag tech platform and farmer-to-farmer network with a mission to power the prosperity of family farmers around the world, while working towards a sustainable future. Its Farmers First® promise has attracted over 14,000 members to the network with a common goal of maximizing their farm’s profit potential. FBN has set out to redefine value and convenience for farmers by helping reduce the cost of production and maximize the value of their crops.

The FBN network has grown to cover more than 40 million acres of member farms in the U.S., Canada and Australia. Blending the best of Midwestern agricultural roots and Silicon Valley technology, the company has over 600 personnel and offices in San Carlos, Calif., Chicago, Sioux Falls, S.D., a Canadian headquarters in High River, Alta., and an Australian headquarters in Perth.

To learn more, visit: www.fbn.com.

Copyright ©2020 Farmer's Business Network, Inc. All rights reserved. The sprout logo, “Farmers Business Network”, “FBN”, “Farmers First” and the Farmers First flag logo are registered service marks of Farmer’s Business Network, Inc. All other marks are the property of their respective owners.

Copyright ©2020 GRO Network. All rights reserved. “GRO Network” and the GRO Network logo are registered trademarks of GRO Network.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media:
Keith Chapman
Chap Public Relations
Keith@chappublicrelations.com
847-970-2171

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye